Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) traded up 10.9% during trading on Wednesday . The company traded as high as $0.25 and last traded at $0.25. 1,764 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 12,026 shares. The stock had previously closed at $0.22.
Alpha Tau Medical Stock Down 13.0 %
The stock has a 50 day simple moving average of $0.20 and a 200 day simple moving average of $0.21.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- Why is the Ex-Dividend Date Significant to Investors?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What is a Bond Market Holiday? How to Invest and Trade
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
